SCHEMBL4826293

SCHEMBL4826293

CCc1cccc(CC)c1-c1cc(OC)c(CCOC(C)C2CCC2)cn1

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 20/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4826294 0.81 C5AR1 (0.40) C5AR1
SCHEMBL1328368 0.78 C5AR1 (0.39) C5AR1
SCHEMBL4826301 0.76 C5AR1 (0.40) C5AR1
SCHEMBL6520800 0.76 ALOX5 (0.43) C5AR1
SCHEMBL6523352 0.76 C5AR1 (0.38) C5AR1
SCHEMBL6522043 0.74 PPARA (0.49)
SCHEMBL1327003 0.73 C5AR1 (0.48) C5AR1
SCHEMBL1328376 0.73 C5AR1 (0.40) C5AR1
SCHEMBL2138911 0.72 C5AR1 (0.42) C5AR1
SCHEMBL1328940 0.72 NPSR1 (0.43) C5AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342115-B2 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology NEUROGEN CORPORATION (US) 2008-03-11 US disclosed